Structural Prediction of Viral Envelope Glycoproteins Using AlphaFold2: Implications for Host Receptor Binding and Vaccine Design

Introduction

Viral envelope glycoproteins mediate host cell entry by recognizing specific receptors and catalyzing membrane fusion. These proteins are primary targets for neutralizing antibodies and constitute the principal antigenic components of many veterinary vaccines. Accurate three-dimensional structural knowledge of these glycoproteins is essential for understanding receptor binding specificity, conformational transitions, and immune evasion mechanisms. Traditional experimental structure determination methods such as X-ray crystallography and cryo-electron microscopy (cryo-EM) remain resource intensive and are not always feasible for rapidly emerging viral variants or poorly expressed envelope proteins. The advent of deep learning-based protein structure prediction, particularly AlphaFold2, has transformed structural virology by enabling accurate modeling of viral glycoproteins from primary sequence alone [1]. This article reviews the application of AlphaFold2 to predict structures of viral envelope glycoproteins, with emphasis on class I fusion proteins, receptor binding dynamics, and structure-based vaccine design for veterinary pathogens.

AlphaFold2 Architecture and Application to Viral Glycoproteins

AlphaFold2 employs a neural network architecture that integrates multiple sequence alignments (MSAs) with pairwise residue distance predictions to generate atomic coordinates with high accuracy. The model was benchmarked in the Critical Assessment of Structure Prediction (CASP) experiment, where it successfully modeled several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins, including the spike glycoprotein, demonstrating its utility for viral targets [1]. Subsequent studies have extended AlphaFold2 to predict both pre-fusion and post-fusion conformations of class I fusion proteins, a feat that requires capturing large-scale conformational rearrangements [2]. The ability to predict multiple conformational states is critical because envelope glycoproteins undergo dramatic structural changes during receptor binding and membrane fusion.

For veterinary virology, AlphaFold2 has been applied to model the Gp5/M dimer of porcine reproductive and respiratory syndrome virus (PRRSV), a major swine pathogen [3]. The predicted structure revealed the arrangement of the ectodomain and transmembrane regions, providing insights into antibody accessibility and fusion mechanisms. Similarly, the hemagglutinin (HA) stem of influenza B virus has been modeled using AlphaFold2 to guide the design of broadly protective vaccines [4]. These examples illustrate the platform's versatility across diverse viral families.

Predicting Conformational Ensembles and Receptor Binding Dynamics

Envelope glycoproteins exist as dynamic ensembles of conformations rather than static structures. AlphaFold2, when combined with molecular dynamics (MD) simulations, can generate conformational ensembles that capture the plasticity of receptor binding domains (RBDs). For SARS-CoV-2 spike protein variants, AlphaFold2-based structural ensembles have been used to map mutational effects on angiotensin-converting enzyme 2 (ACE2) receptor affinity and antibody escape [5, 6, 7, 8]. These studies revealed epistatic couplings between convergent mutational hotspots that modulate binding energetics, a phenomenon relevant to understanding host range and cross-species transmission in veterinary coronaviruses.

The application of AlphaFold2 to predict RBD-ACE2 complexes has been extended to Omicron sublineages, demonstrating that the model can recapitulate experimentally observed binding affinities and identify escape hotspots for neutralizing antibodies [5, 8]. For veterinary pathogens such as feline coronavirus or bovine coronavirus, similar approaches could predict receptor binding specificity and inform host range predictions. The structural bioinformatics of viral envelope proteins and entry mechanisms is further discussed in the companion article Structural Bioinformatics of Viral Envelope Proteins and Entry Mechanisms.

Comparison with Experimental Structures and Refinement via Molecular Dynamics

AlphaFold2 predictions generally show high agreement with experimentally determined structures, particularly for well-ordered domains. However, flexible loops, glycans, and membrane-proximal regions often exhibit lower confidence. For the SARS-CoV-2 spike, AlphaFold2 models have been compared with cryo-EM structures, revealing close matches in the RBD and core domains but deviations in the N-terminal domain and furin cleavage site [1]. MD simulations are routinely employed to refine AlphaFold2 models by relaxing steric clashes, optimizing side-chain rotamers, and sampling alternative conformations [5, 6, 7]. This hybrid approach improves the accuracy of binding free energy calculations and enables the identification of cryptic epitopes.

In the context of veterinary viruses, MD refinement of AlphaFold2 models has been applied to the P37 envelope protein of monkeypox virus, a zoonotic orthopoxvirus, to identify potential inhibitors [9]. The combination of machine learning and classical MD allowed the screening of small molecules targeting the envelope protein, demonstrating a pipeline that can be adapted for other veterinary pathogens.

Implications for Structure-Based Vaccine Design

Structure-based vaccine design relies on atomic-level knowledge of antigenic sites to engineer immunogens that elicit broadly neutralizing antibodies. AlphaFold2 has enabled the computational design of protein nanoparticle vaccines by predicting the structures of building blocks that self-assemble into multivalent scaffolds [10]. These nanoparticles can display multiple copies of viral glycoprotein fragments, enhancing immunogenicity. For influenza B, an HA stem vaccine designed using AlphaFold2 conferred broad protection in animal models [4]. The stem region is highly conserved across influenza B lineages, making it an attractive target for universal vaccines.

For veterinary applications, similar strategies can be applied to pathogens such as PRRSV, avian influenza virus, and rabies virus. The Gp5/M dimer structure predicted by AlphaFold2 for PRRSV [3] provides a template for designing stabilized pre-fusion immunogens. Additionally, the prediction of epitopes using AlphaFold2 combined with protein-protein docking can identify synthetic binding proteins that block receptor attachment [11]. This approach is relevant for developing entry inhibitors and diagnostic reagents.

The following Mermaid diagram summarizes the workflow for AlphaFold2-based vaccine antigen design:

flowchart TD
    A[Viral glycoprotein sequence], > B[AlphaFold2 structure prediction]
    B, > C{Confidence assessment}
    C, >|High pLDDT| D[Model selection]
    C, >|Low pLDDT| E[MD refinement]
    E, > D
    D, > F[Receptor docking simulation]
    F, > G[Binding energetics analysis]
    G, > H[Identify conserved epitopes]
    H, > I[Design stabilized immunogens]
    I, > J[Nanoparticle scaffold design]
    J, > K[In vitro/in vivo testing]

Antiviral Drug Targeting and Host Receptor Interactions

Beyond vaccine design, AlphaFold2 predictions facilitate the identification of druggable pockets on envelope glycoproteins. The transmembrane domain of the SARS-CoV-2 spike, for example, plays a critical role in palmitoylation and membrane fusion, and its structure can inform the design of fusion inhibitors [12]. For veterinary coronaviruses such as porcine epidemic diarrhea virus (PEDV) or transmissible gastroenteritis virus (TGEV), similar targeting strategies are feasible.

Host receptor interactions can be modeled using AlphaFold2 in complex with receptor structures. The interaction between SARS-CoV-2 spike and neuropilin-1, an alternative entry receptor, was characterized biophysically, and AlphaFold2 contributed to modeling the binding interface [13]. For veterinary viruses that utilize multiple receptors, such as avian influenza virus binding to sialic acid receptors of different linkages, AlphaFold2 can predict how mutations in the HA receptor binding site alter specificity. This topic is explored in detail in the article Structural Comparison of Avian Versus Mammalian Influenza Receptor Binding.

Limitations and Future Directions

Despite its successes, AlphaFold2 has limitations in predicting the structures of heavily glycosylated proteins, membrane-embedded regions, and large conformational rearrangements. The prediction of post-fusion conformations of class I fusion proteins often requires specialized protocols or the use of multiple sequence alignments from related viruses [2]. Additionally, the model does not account for the dynamic nature of glycans, which are critical for immune evasion. Integration with glycan modeling tools and enhanced sampling MD simulations is necessary to overcome these challenges.

For veterinary virology, the application of AlphaFold2 to non-model organisms may be hindered by limited sequence diversity in MSAs. However, the growing number of viral genome sequences in databases such as NCBI Virus and GISAID (for influenza) is expanding the coverage. The use of AlphaFold2 for predicting host-range transitions and zoonotic potential is discussed in the article Deep Learning for Predicting Viral Host-Range Transitions and Zoonotic Potential.

Conclusion

AlphaFold2 has emerged as a transformative tool for predicting the structures of viral envelope glycoproteins, enabling detailed analysis of receptor binding, conformational dynamics, and immune evasion. When combined with MD simulations and experimental validation, these predictions accelerate the design of vaccines and antiviral agents for veterinary pathogens. The continued development of deep learning methods, including AlphaFold3, promises further improvements in modeling protein-ligand interactions and glycoprotein complexes, as reviewed in AlphaFold 3 in Molecular Biology: Predicting Protein-Ligand Interactions and Viral Glycoproteins. The integration of structural prediction with immunoinformatics and nanoparticle design will drive the next generation of veterinary vaccines.

References

[1] Kryshtafovych A, Moult J, Billings WM et al. Modeling SARS-CoV-2 proteins in the CASP-commons experiment. Proteins. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34462960/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[2] Gülesen S, Most V, Schoeder CT et al. Prediction of pre- and postfusion conformations of class I fusion proteins with AlphaFold2. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42302011/

[3] Veit M, Gadalla MR, Zhang M. Using Alphafold2 to Predict the Structure of the Gp5/M Dimer of Porcine Respiratory and Reproductive Syndrome Virus. Int J Mol Sci. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/36361998/

[4] Zeng D, Xin J, Yang K et al. A Hemagglutinin Stem Vaccine Designed Rationally by AlphaFold2 Confers Broad Protection against Influenza B Infection. Viruses. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35746776/

[5] Raisinghani N, Alshahrani M, Gupta G et al. AlphaFold2 Modeling and Molecular Dynamics Simulations of the Conformational Ensembles for the SARS-CoV-2 Spike Omicron JN.1, KP.2 and KP.3 Variants: Mutational Profiling of Binding Energetics Reveals Epistatic Drivers of the ACE2 Affinity and Escape Hotspots of Antibody Resistance. Viruses. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39339934/

[6] Raisinghani N, Alshahrani M, Gupta G et al. Exploring conformational landscapes and binding mechanisms of convergent evolution for the SARS-CoV-2 spike Omicron variant complexes with the ACE2 receptor using AlphaFold2-based structural ensembles and molecular dynamics simulations. Phys Chem Chem Phys. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38869513/

[7] Raisinghani N, Alshahrani M, Gupta G et al. AlphaFold2 Predictions of Conformational Ensembles and Atomistic Simulations of the SARS-CoV-2 Spike XBB Lineages Reveal Epistatic Couplings between Convergent Mutational Hotspots that Control ACE2 Affinity. J Phys Chem B. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38696745/

[8] Raisinghani N, Alshahrani M, Gupta G et al. AlphaFold2-Enabled Atomistic Modeling of Structure, Conformational Ensembles, and Binding Energetics of the SARS-CoV-2 Omicron BA.2.86 Spike Protein with ACE2 Host Receptor and Antibodies: Compensatory Functional Effects of Binding Hotspots in Modulating Mechanisms of Receptor Binding and Immune Escape. J Chem Inf Model. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38373700/

[9] Rout M, Dey S, Mishra S et al. Machine learning and classical MD simulation to identify inhibitors against the P37 envelope protein of monkeypox virus. J Biomol Struct Dyn. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/37221882/

[10] Haas CM, Jasti N, Dosey A et al. From sequence to scaffold: Computational design of protein nanoparticle vaccines from AlphaFold2-predicted building blocks. Proc Natl Acad Sci U S A. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41183183/

[11] Mijit A, Li Y, Xue W. Predicting Epitopes of Synthetic Binding Proteins Using Protein Structure Prediction and Protein-Protein Docking. Methods Mol Biol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40593425/

[12] Abdulrahman DA, Veit M. Role of the transmembrane domain in severe acute respiratory syndrome (SARS) coronavirus 2 spike for palmitoylation and membrane fusion. Protein Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41575059/

[13] Hou D, Cao W, Kim S et al. Biophysical investigation of interactions between SARS-CoV-2 spike protein and neuropilin-1. Protein Sci. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37656811/

[14] Orfanoudaki M, Krumpe LRH, Shenoy SR et al. Isolation and structure elucidation of Dm-CVNH, a new cyanovirin-N homolog with activity against SARS-CoV-2 and HIV-1. J Biol Chem. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39956341/

[15] Cambillau C, Goulet A. Exploring Host-Binding Machineries of Mycobacteriophages with AlphaFold2. J Virol. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/36916948/